Compounded tirzepatide
Sold by Novi · Injection, vial · every compounded tirzepatide record
What you actually pay
Per month
$179
| Medication · Month to month | $179 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Month to month “1 month $179” | Per month$179 | Charged today$179 |
| 3-month plan “3 month $149” | Per month$149 | Charged today$149 |
| 6-month plan “6 month $133” | Per month$133 | Charged today$133 |
| 12-month plan “12 month $129” | Per month$129 | Charged today$129 |
We earn nothing from this link. Novi has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 3, 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Not disclosed |
|---|---|
| States | All 50 states |
| Prescriber | Both |
| Cancellation | “We're so confident in our program that if you complete your first four months of treatment and don't make meaningful progress toward your goals, you'll be eligible for a full refund under our Progress Promise.” |
| Membership | Not disclosed |
| Consult fee | Not disclosed |
Recorded from joinnovi.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 3, 2026 — Novi prices compounded tirzepatide under a heading that reads “Billing cycle / Per month”, so each figure is a monthly rate: $179 month to month, $149 on three months, $133 on six and $129 on twelve. The page states what the figure covers — “Price includes everything you need: consultation, care, medication, supplies, shipping and support” — and adds “No membership or hidden fees” and “Same price no matter the dose”. It never says a longer plan is paid up front, so the amount recorded as charged today is one month rather than the whole term.
- 2. September 3, 2026 — Novi's home page is not where its prices are. It is titled “Summer Promo” and leads with “Was $299 Now starting at $133/mo”, the $299 struck through, beside a counter reading “Price increases in”. That counter does not appear to count down to anything: two readings hours apart on 3 September 2026 showed thirteen hours remaining and then twenty-three hours fifty-nine minutes remaining. The same page advertises “Up to $200 OFF” on semaglutide and “Up to $250 OFF” on tirzepatide, which are discounts rather than prices, and lists Mounjaro®, Ozempic®, Wegovy® and Zepbound® as “Started at $1500” with no period attached. The figures recorded here come from the product pages instead, which price each plan per month and name the billing cycle.
- 3. September 3, 2026 — Novi says it serves “all 50-states and the District of Columbia”. Treatment begins without a video visit in most states, and it names Kansas, Louisiana, Mississippi, New Mexico and West Virginia as requiring a brief video or audio visit first. It also says plainly that it is not a pharmacy and does not name the pharmacy that fills its prescriptions.
1 further note concerns other Novi programs and sit on the provider record.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.